Treatment session frequency and smoking cessation.
In a retrospective program evaluation analysis, we compared abstinence rates in 78 smokers participating in a 2-, 3-, or 6-week clinic-based behavioral-pharmacological smoking cessation program. The three treatment formats consisted of six sessions that varied in session frequency. Retention and end-of-treatment smoking cessation rates were best in the medium-frequency (3-week) and high-frequency (2-week) treatment session formats. One-year follow-up abstinence rates were highest in the medium-frequency format, and lowest in the high-frequency format. A significant patient-treatment interaction effect was found for pretreatment smoking rate. Individuals with lower pretreatment smoking rates benefited most with respect to end-of-treatment cessation rates from the medium- and high-frequency treatment session format. However, this effect was not significant at the 1-year follow-up. The need for prospective research and patient-to-treatment matching implications in smoking cessation programs are discussed.
Schmitz
J M
JM
University of Texas Medical School, Houston.
Tate
J C
JC
D000328:Adult; D000704:Analysis of Variance; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D009538:Nicotine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011109:Polymethacrylic Acids / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D012008:Recurrence; D012720:Severity of Illness Index; D012907:Smoking / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D016540:Smoking Cessation; D061485:Tobacco Use Cessation Devices; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine